BEAM - Beam Therapeutics President and CSO Acquires 90900 Shares After Exercising Company Stock Options | Benzinga
Giuseppe Ciaramella, President and CSO at Beam Therapeutics (NASDAQ:BEAM), reported a large exercise of company stock options on October 24, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Ciaramella, President and CSO at Beam Therapeutics, a company in the Health Care sector, just exercised stock options worth 90,900 shares of BEAM stock with an exercise price of $0.67.
Beam Therapeutics shares are trading down 0.31% at $19.47 at the time of this writing on Wednesday morning. Since the current price is $19.47, this makes Ciaramella's 90,900 shares worth $1,769,823.
Now trade stocks online commission free with Charles Schwab, ...